PL377557A1 - Zastosowanie rezweratrolu do otrzymywania leku użytecznego w leczeniu infekcji wywołanej wirusem grypy - Google Patents

Zastosowanie rezweratrolu do otrzymywania leku użytecznego w leczeniu infekcji wywołanej wirusem grypy

Info

Publication number
PL377557A1
PL377557A1 PL377557A PL37755703A PL377557A1 PL 377557 A1 PL377557 A1 PL 377557A1 PL 377557 A PL377557 A PL 377557A PL 37755703 A PL37755703 A PL 37755703A PL 377557 A1 PL377557 A1 PL 377557A1
Authority
PL
Poland
Prior art keywords
resveratrol
receive
treatment
influenza virus
virus infection
Prior art date
Application number
PL377557A
Other languages
English (en)
Other versions
PL217628B1 (pl
Inventor
Enrico Garaci
Anna Teresa Palamara
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL377557A1 publication Critical patent/PL377557A1/pl
Publication of PL217628B1 publication Critical patent/PL217628B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL377557A 2002-11-06 2003-10-14 Zastosowanie resweratrolu do wytwarzania leku wywierającego działanie inhibitorowe na replikację wirusa grypy do zapobiegania i/lub leczenia infekcji wywołanej wirusem grypy PL217628B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000562A ITRM20020562A1 (it) 2002-11-06 2002-11-06 Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.

Publications (2)

Publication Number Publication Date
PL377557A1 true PL377557A1 (pl) 2006-02-06
PL217628B1 PL217628B1 (pl) 2014-08-29

Family

ID=32310188

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377557A PL217628B1 (pl) 2002-11-06 2003-10-14 Zastosowanie resweratrolu do wytwarzania leku wywierającego działanie inhibitorowe na replikację wirusa grypy do zapobiegania i/lub leczenia infekcji wywołanej wirusem grypy

Country Status (18)

Country Link
US (1) US8431617B2 (pl)
EP (1) EP1567137B1 (pl)
JP (1) JP4589118B2 (pl)
KR (1) KR101060331B1 (pl)
AR (1) AR041891A1 (pl)
AT (1) ATE381929T1 (pl)
AU (1) AU2003279551A1 (pl)
CA (1) CA2504872C (pl)
CY (1) CY1107302T1 (pl)
DE (1) DE60318327T2 (pl)
DK (1) DK1567137T3 (pl)
ES (1) ES2295660T3 (pl)
IT (1) ITRM20020562A1 (pl)
MX (1) MXPA05004628A (pl)
PL (1) PL217628B1 (pl)
PT (1) PT1567137E (pl)
TW (1) TWI337863B (pl)
WO (1) WO2004041260A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009515933A (ja) * 2005-11-18 2009-04-16 アレス トレーディング ソシエテ アノニム インフルエンザにおけるインターフェロン
WO2009136979A2 (en) * 2008-03-06 2009-11-12 Mount Sinai School Of Medicine Of New York University Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof
WO2010053949A1 (en) * 2008-11-04 2010-05-14 Metaproteomics, Llc Phytochemical compositions and methods for activating amp-kinase
EP2373329A4 (en) * 2008-12-19 2012-07-04 Univ California USE OF INGREDIENTS OF THE EPIDERMAL GROWTH FACTOR IN THE TREATMENT OF VIRUS INFECTIONS
KR100950445B1 (ko) 2009-10-26 2010-04-02 주식회사 중앙백신연구소 감초로부터 얻은 조류, 돼지 인플루엔자 및 신종플루에 대한 항바이러스제
US9096585B2 (en) 2010-05-28 2015-08-04 Icahn School Of Medicine At Mount Sinai Antiviral compounds and uses thereof
US9453017B2 (en) * 2011-09-30 2016-09-27 Vanderbilt University Antiviral therapies with phospholipase D inhibitors
PT2952209T (pt) 2014-06-04 2018-05-09 Alfasigma Spa Formulações homogéneas compreendendo ácidos gordos poliinsaturados ómega-3 (n-3 pufa) e resveratrol para administração oral
EP2952180B1 (en) 2014-06-04 2017-01-25 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Solid formulations containing resveratrol and omega-3 polyunsaturated fatty acids (n-3 PUFA)
EP3120842A1 (en) 2015-07-20 2017-01-25 Opterion Health AG Peritoneal therapeutic fluid
KR20170039456A (ko) 2015-10-01 2017-04-11 동아대학교 산학협력단 오동나무로부터 추출한 ｃ-제라닐플라보노이드계 물질을 포함하는 인플루엔자 예방 및 치료용 약학 조성물
JP2018024592A (ja) * 2016-08-09 2018-02-15 株式会社ブレインヘルス 抗生物質含有組成物
CN108893558B (zh) * 2018-05-24 2022-04-05 江苏海宏制药有限公司 一种桑木液原液抗病毒实验方法以及装置
US11903921B2 (en) 2020-04-05 2024-02-20 Michael Mong Systems and methods for treating coronavirus
WO2026044308A1 (en) 2024-08-26 2026-03-05 Medizinische Universität Wien Treatment and prevention of diseases caused by influenza virus with 3,3',4,4',5,5'-hexahydroxy-trans-stilbene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
PE20010540A1 (es) 1999-07-30 2001-05-15 Procter & Gamble Composicion de fitoalexinas estilbenicas util para la profilaxis y tratamiento de sintomas asociados con el resfriado y enfermedades similares a la influenza
WO2001012228A2 (en) 1999-08-13 2001-02-22 University Of Maryland Biotechnology Institute Compositions for treating viral infections, and methods therefor

Also Published As

Publication number Publication date
JP2006507295A (ja) 2006-03-02
ITRM20020562A1 (it) 2004-05-07
CY1107302T1 (el) 2012-11-21
US8431617B2 (en) 2013-04-30
PL217628B1 (pl) 2014-08-29
TW200501935A (en) 2005-01-16
EP1567137B1 (en) 2007-12-26
AR041891A1 (es) 2005-06-01
JP4589118B2 (ja) 2010-12-01
ATE381929T1 (de) 2008-01-15
DK1567137T3 (da) 2008-04-28
ES2295660T3 (es) 2008-04-16
KR20050071627A (ko) 2005-07-07
MXPA05004628A (es) 2005-09-08
WO2004041260A1 (en) 2004-05-21
CA2504872A1 (en) 2004-05-21
AU2003279551A1 (en) 2004-06-07
DE60318327T2 (de) 2008-12-18
US20050239906A1 (en) 2005-10-27
CA2504872C (en) 2011-07-05
PT1567137E (pt) 2008-02-19
KR101060331B1 (ko) 2011-08-30
EP1567137A1 (en) 2005-08-31
DE60318327D1 (de) 2008-02-07
TWI337863B (en) 2011-03-01

Similar Documents

Publication Publication Date Title
EP1924281A4 (en) MODIFIED INFLUENZA VIRUS FOR MONITORING AND IMPROVING VACCINE EFFECTIVENESS
NO20043494L (no) Infeksjonsresistent medisinsk innretning
NO20070988L (no) Vaksine for forebygging og behandling av HIV-infeksjon
NO20030832D0 (no) Kondenserte cykliske forbindelser og medisinsk anvendelse derav
DE60322582D1 (de) Oberflächenbehandlung von medizinischem gerät
DE60312780D1 (de) Wegwerfwindel
NO20054608D0 (no) Influensavirusvaksine
DE602004027932D1 (de) Benzimidazolderivate: herstellung und pharmazeutische anwendungen
DE60203429D1 (de) Absorbierender Wegwerfartikel
ATE413188T1 (de) Menschliche papillomavirus impfstoff- formulierungen
DE602004018587D1 (de) Staubschützende Wegwerfmaske
EP1307130A4 (en) VACCINE AGAINST THE VIRUS OF HUMAN IMMUNODEFICIENCY
DE60313070D1 (de) Einwegbremsvorrichtung
EE200300311A (et) Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim
DE50308640D1 (de) Veterinärmedizinische spritze
NO20031565L (no) Engangsspröyte
DK1265577T3 (da) Medicinsk eller dentalmedicinsk behandlingsstol
DK1567137T3 (da) Anvendelse af resveratrol til fremstilling af et medikament, der er anvendeligt til behandling af influenzavirusinfektioner
DK1670482T4 (da) Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
ATE507831T1 (de) Melatonin enthaltende pharmazeutische formulierung
ATE392903T1 (de) Impfstoff gegen pferdeherpesvirus
IS7825A (is) Meðferðarfræðileg meðhöndlun
DE50303099D1 (de) Patientenlagerungstisch
EP1765330A4 (en) PYRANOINDOLE DERIVATIVES AND USE THEREOF FOR THE TREATMENT OF DISEASE OR INFECTION CAUSED BY HEPATITIS C VIRUS
ATE437656T1 (de) Impfstoff gegen das maul- und klauensäure-virus